FTC, June 7, 2022 Agency to Scrutinize the Impact of Vertically Integrated Pharmacy Benefit Managers on the Access and Affordability of Medicine The Federal Trade Commission announced today that it will launch an inquiry into the prescription drug middleman industry, requiring the six largest pharmacy benefit managers to provide information and records regarding their business…Continue Reading FTC Launches Inquiry Into Prescription Drug Middlemen Industry
FTC Launches Inquiry Into Prescription Drug Middlemen Industry
